Oncology Institute Ratios (2020-2025) | TOI

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 52.48%52.70%51.43%47.71%50.37%46.04%44.40%46.26%43.81%44.06%45.19%43.62%47.71%52.81%14.38%166.73%54.91%57.30%13.85%
EBT Margin -1.60%7.99%-4.17%-24.14%35.29%-9.00%-4.15%-15.92%-39.31%-20.94%-21.07%-22.23%-21.01%-15.70%-16.13%-13.15%-18.76%-14.31%-12.09%
EBIT Margin -3.61%-2.24%-4.13%-78.07%-33.49%-30.05%-30.93%-35.11%-43.14%-18.62%-16.97%-17.82%-18.98%-16.60%-13.87%-11.90%-9.49%-9.36%-5.90%
EBITDA Margin -3.27%-1.89%-3.70%-77.56%-32.92%-29.46%-30.32%-34.47%-42.43%-17.87%-15.86%-16.88%-18.23%-15.84%-13.07%-10.97%-8.52%-8.50%-5.16%
Operating Margin -3.61%-2.24%-4.13%-78.07%-33.49%-30.05%-30.93%-35.11%-43.14%-18.62%-16.97%-17.82%-18.98%-16.60%-13.87%-11.90%-9.49%-9.36%-5.90%
Net Margin -2.05%-12.28%-0.66%-18.99%34.96%-8.95%-4.12%-15.41%-39.37%-21.06%-21.23%-21.86%-21.01%-12.86%-13.24%-10.80%-18.76%-11.68%-10.08%
FCF Margin -0.32%-15.12%-6.94%-46.28%-32.60%-19.24%-33.23%-22.39%-22.69%-11.96%-11.26%-5.54%-17.42%-17.74%1.22%2.24%-5.09%-9.52%-9.69%
Efficiency
Inventory Average 7.10M8.18M9.30M9.64M9.76M11.21M12.17M12.93M12.62M11.44M10.71M10.07M11.17M14.05M17.33M
Assets Average 231.66M231.43M148.54M148.36M230.90M230.53M216.87M204.98M198.13M236.77M272.73M248.15M232.30M224.16M213.80M206.89M192.07M179.39M175.95M168.36M161.90M161.71M
Equity Average -17.78M-20.30M3.30M37.62M48.77M48.97M75.85M118.08M127.99M125.96M125.55M110.79M91.56M78.29M64.44M49.16M35.25M22.34M9.54M4.33M-1.96M-10.63M
Invested Capital -16.47M-19.09M-21.51M33.47M47.15M50.40M47.53M104.16M132.00M123.98M207.00M203.80M180.55M168.41M157.10M143.85M129.68M119.16M107.02M96.72M78.96M66.04M63.92M
Asset Utilization Ratio 0.330.430.650.941.021.110.990.931.101.261.381.521.661.882.112.242.392.622.85
Leverage & Solvency
Interest Coverage Ratio -17.36-13.78-249.61-300.07-9.12-7.93-7.88-9.05-7.73-6.23-10.21-1.78-6.00-4.19
Debt to Equity 0.420.000.620.650.830.991.191.522.143.085.9125.9514.58-8.35-6.21
Debt Ratio 0.180.000.280.310.350.360.390.410.430.500.510.540.450.470.47
Equity Ratio -0.07-0.08-0.090.430.200.220.210.510.640.650.450.470.420.370.330.270.200.160.090.020.03-0.06-0.08
Times Interest Earned -17.36-13.78-249.61-300.07-9.12-7.93-7.88-9.05-7.73-6.23-10.21-1.78-6.00-4.19
Valuation
Enterprise Value -1.51M-1.10M-1.00M-6.00M-27.41M-15.17M-11.53M-115.17M-95.53M-64.21M-90.58M-73.81M-55.38M-39.18M-87.41M-82.86M-65.83M-46.36M-47.40M-49.67M-39.74M-30.29M-27.66M
Return Ratios
Return on Sales -0.02%0.06%-0.06%-0.19%0.35%-0.09%-0.04%-0.15%-0.39%-0.21%-0.21%-0.22%-0.21%-0.16%-0.16%-0.13%-0.19%-0.14%-0.12%
Return on Capital Employed -0.07%-0.05%-0.06%-0.25%-0.36%-0.49%-0.48%-0.34%-0.44%-0.47%-0.45%-0.43%-0.39%-0.40%-0.48%-0.49%-0.48%-0.48%-0.43%
Return on Invested Capital -0.23%-0.30%-0.57%-0.57%0.53%0.44%0.67%-0.50%-0.53%-0.53%-0.51%-0.45%-0.51%-0.56%-0.65%-0.63%
Return on Assets -0.09%-0.10%-0.04%-0.04%-0.05%0.05%0.00%0.00%0.00%-0.20%-0.26%-0.34%-0.39%-0.35%-0.37%-0.39%-0.37%-0.38%-0.41%-0.41%
Return on Equity -4.11%-0.39%-0.18%-0.19%-0.14%0.08%0.01%0.01%0.00%-0.44%-0.66%-0.96%-1.29%-1.48%-2.03%-3.14%-6.78%-14.87%33.65%6.24%